A major portion of the mammalian genome is transcribed to produce large numbers of noncoding RNAs (ncRNAs). During the past decade, the discovery of small RNAs, including the microRNAs (miRNA) and small interfering RNAs (siRNA), has led to important advances in biology. The breadth of the ncRNA field of study has substantially expanded and many recent results have revealed a range of functions that can be attributed to the miRNAs and other ncRNAs. For example, H19 RNA, HOTAIR RNA, transcribed ultraconserved regions (T-UCRs), natural antisense RNA, transfer RNA and mitochondrial noncoding RNA have been suggested to play important roles in cancers and other diseases as well as in diverse cellular processes. In this review, we focus on the current status of several classes of ncRNAs associated with cancer with the emphasis on those that are not microRNAs. Mounting evidence has revealed that a major portion of the mammalian genome is transcribed to produce large numbers of noncoding RNAs (ncRNAs), that is, RNAs that either do not have an open reading frame or RNAs that have a short poorly conserved open reading frame and do not code for a protein [1,2]. During the past decade, the discovery of small RNAs including the microRNAs (miRNAs) and small interfering RNAs (siRNAs) has led to major advances in biology. After miRNAs were first connected to cancer pathogenesis [3], accumulating data have pointed to a central regulatory role for miRNAs in the initiation and progression of most of the cancers that have been analyzed so far. Recently, the breadth of the ncRNA field of study has substantially expanded. A series of studies have revealed the essential roles of many ncRNAs in diverse cellular processes including cancer; these ncRNAs include H19 RNA, HOTAIR RNA, transcribed ultraconserved regions (T-UCRs), natural antisense RNA, transfer RNA and mitochondrial noncoding RNA (Figure 1). In this review, we focus on the current status of the research into the several classes of ncRNAs associated with cancer.